Drug Search Results
More Filters [+]

Chlorproguanil

Alternative Names: chlorproguanil
Latest Update: 2020-09-18
Latest Update Note: News Article

Product Description

Chlorproguanil has been used in trials studying the treatment of MALARIA. It is a dichloro-derivative of chloroguanide. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Chlorproguanil)

Mechanisms of Action: DHFR Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: GlaxoSmithKline
Company Location: BRENTFORD MIDDLESEX X0 TW8 9GS
Company CEO: Emma Walmsley
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Chlorproguanil

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Malaria, Falciparum

Phase 3: Malaria, Vivax|Malaria, Falciparum|Malaria

Phase 1: Malaria

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ITCRVG04

P3

Completed

Malaria

2007-09-01

DIF 35

P3

Terminated

Malaria

2007-08-01

CDA 714703/005

P3

Completed

Malaria, Falciparum

2007-08-01

CDA 714703/006

P3

Completed

Malaria, Falciparum

2007-05-01

Recent News Events